| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.001 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.099 | 0.001 |